The quantitative analysis of zearalenone and its derivatives in plasma of patients with breast and cervical cancer

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 9, 2002, Pages 946-951

  Pillay, Dharmarai ^a   Churturgoon, Anil A ^a   Nevines, Elena ^a   Manickum, Thavrin ^a   Deppe, Walter ^a   Dutton, Michael F ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Breast cancer; Cervical cancer; Gas chromatography mass spectrometry (GC MS); Zearalenone; zearalenol; zearalenol

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; MYCOTOXIN; ZEARALENONE; DRUG DERIVATIVE;

ANALYSIS OF VARIANCE; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BREAST CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTROGEN ACTIVITY; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; STATISTICAL SIGNIFICANCE; TARGET CELL; TOXIN ANALYSIS; UTERINE CERVIX CANCER; BLOOD; BREAST TUMOR; MASS FRAGMENTOGRAPHY; UTERINE CERVIX TUMOR;

ZEA MAYS;

ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; UTERINE CERVICAL NEOPLASMS; ZEARALENONE;

EID: 0036405920     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.166     Document Type: Article

References (20)

1. Sitas F, Madhoo J, Wessie J. Incidence of histologically diagnosed cancer in South Africa, 1993-1995. National Cancer Registry of South Africa. Johannesburg, 1998.
2. Kuiper-Goodman T, Scott PM, Watanabe H. Risk assessment of the mycotoxin zearalenone. Regul Toxicol Pharmacol 1987; 7:253-306.
3. Marasas WFO, Kriek NJ, van Rensburg SJ, Steyn M, van Schalkwyk GC. Occurrence of zearalenone and deoxynivalenol mycotoxins produced by Fusarium graminearium in maize in South Africa. South African J Sci 1977; 73:346-9.
4. Marasas WFO, van Rensburg SJ, Mirocha CJ. Incidence of Fusarium species and the mycotoxins, deoxynivalenol and zearalenone in corn produced in oesophageal cancer in Transkei. Agri Food Chem 1979; 27:1108-12.
5. Shier WT. Estrogenic mycotoxins. Revue Met Vet 1998; 149:599-604.
6. Trenholm LH, Warner RM, Farnworth ER. High performance chromatographic method using flourescence detection for quantitative analysis of zearalenone and α-zearalenol in blood plasma. J Assoc Off Anal Chem 1981; 64:302-10.
7. Mirocha CJ, Pathre SV. Mycotoxins - their biosynthesis in fungi: zearalenone biosynthesis. J Food Prot 1979; 42:821-4.
8. Prelusky DB, Warner RM, Trenholm HL. Sensitive analysis of the mycotoxin zearalenone and its metabolites in biological fluids by high performance liquid chromatography. J Chromatogr 1989; 494:267-77.
9. Kiessling KH, Pattersson H. Metabolism of zearalenone in rat liver. Acta Pharmacol Toxicol 1978; 43:285-90.
10. Hagler WM, Mirocha CJ, Pathre S, Behrens JC. Identification of the naturally occurring isomer of zearalenol produced by Fusarium roseum 'Gibbosum' in rice culture. Appl Environ Microbiol 1979; 37:849-53.
11. Sonnenschein C, Soto AM, Fernandez MF, Olen N, Olea-Serrano MF, Ruiz-Lopez MD. Development of a marker of estrogenic exposure in human plasma. Clin Chem 1995; 41:1888-95.
12. Strickland PT, Groopman JD. Biomarkers for assessing environmental exposure to carcinogens in the diet. Am J Clin Nutr 1995; 61:710S-20S.
13. Chang WM, Lin JK. Transformation of zearalenone and zearalenol by rat erythrocytes. Food Chem Toxicol 1984; 22:887-91.
14. Rava E. Mycotoxins in maize products of the 1994/5 marketing season. Mycotox Res 1996; 12:25-30.
15. Migdalof BH, Dugger HA, Heider JG, Coombs RA, Terry MK. Biotransformation of zeranol: disposition and metabolism in the female rat, rabbit, dog, monkey and man. Xenobiotica 1983; 13:209-21.
16. Ueno Y, Ayaki S, Ito T. Fate and mode of action of zearalenone. Ann Nutr Aliment 1977; 31:935-48.
17. Pfohl-Leszkowicz A, Chekir-Ghedira L, Bacha H. Genotoxicity of zearalenone, an estrogenic mycotoxin: DNA adduct formation in female mouse tissues. Carcinogenesis 1995; 16:2315-20.
18. Mirocha CJ, Pathre SV, Robison TS. Comparative metabolism of zearalenone and transmission into bovine milk. Food Cosmet Toxicol 1981; 19:25-30.
19. Zia-Amirhosseini P, Spahn-Langguth H, Benet L. Bioactivation by glucuronide-conjugate formation. Adv Pharmacol 1994; 27:385-97.
20. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Bannerjee S, Koeing KL, Shore RE. A prospective study of endogenous oestrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995; 87:190-7.